Isolation of Daudi cells with reduced sensitivity to interferon. II. On the mechanisms of resistance.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of General Virology

• Publication date

  1983-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/0022-1317-64-12-2649PMID 6319552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ppp(A2'p)nA and protein kinase systems in wild-type and interferon-resistant Daudi cells.

  2005cited by this paper
• Kinetic evidence for an activation step following binding of human interferon alpha 2 to the membrane receptors of Daudi cells.

  1983cited by this paper
• Isolation of Daudi cells with reduced sensitivity to interferon. I. Characterization.

  1983cited by this paper
• Interferon and cyclic nucleotides.

  1982cited by this paper
• Mechanisms of interferon action: biochemical and genetic approaches.

  1982cited by this paper
• Enhanced expression of cellular receptors for human interferon α on peripheral lymphocytes from patients with down's syndrome

  1982cited by this paper
• Effects of human γ interferon on cell growth, replication of virus and induction of 2′‐5′oligoadenylate synthetase in three human lymphoblastoid cell lines and K562 cells

  1982cited by this paper
• Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-alpha receptor.

  1982cited by this paper
• Rapid increase in guanosine 3',5'-cyclic-monophosphate interferon treated mouse leukemia L1210 cells: relationship to the development of the antiviral state and inhibition of cell multiplication.

  1981cited by this paper
• The 2-5A (pppA2'p5'A2'p5'A) and protein kinase systems in interferon-treated and control cells.

  1981cited by this paper
• High affinity binding of 125I-Labeled mouse interferon to a specific cell surface receptor. II. Analysis of binding properties.

  1981cited by this paper
• The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products.

  1981cited by this paper
• Binding of 125I‐labelled human αinterferon to human lymphoid cells

  1981cited by this paper
• Increased levels of (2'-5')oligo(A) polymerase activity in human lymphoblastoid cells treated with glucocorticoids.

  1980cited by this paper
• High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor

  1980cited by this paper
• Effect of interferon on concentrations of cyclic nucleotides in cultured cells.

  1979cited by this paper
• A simultaneous protein-binding assay for adenosine 3':5'-monophosphate in biological materials.

  1977cited by this paper
• A simultaneous protein-binding assay for adenosine 3′:5′-monophosphate and guanosine 3′:5′-monophosphate in biological materials

  1977cited by this paper
• A simple, sensitive protein-binding assay for guanosine 3':5'-monophosphate.

  1971cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• Associated With Lack of STAT1 Expression Resistance in a Cutaneous T-Cell Lymphoma Cell Line Is α Interferon-

  2013cites this paper
• Interferon receptors

  2007cites this paper
• Plasma membrane biophysical properties linked to the antiproliferative effect of interferon-alpha.

  2005cites this paper
• Regulation of cell growth by interferon

  2004cites this paper
• Prolonged STAT 1 Activation Related to the Growth Arrest of Malignant Lymphoma Cells by Interferon-a By

  1998cites this paper
• Liposomal delivery of alpha-Interferon to murine bladder tumor cells via transferrin receptor-mediated endocytosis.

  1998cites this paper
• Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression.

  1998cites this paper
• Prolonged STAT1 activation related to the growth arrest of malignant lymphoma cells by interferon-alpha.

  1998cites this paper
• Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells.

  1996cites this paper
• Effects of interferons and tumour necrosis factor-alpha on human lung cancer cell lines and the development of an interferon-resistant lung cancer cell line.

  1996cites this paper
• Opposite Sensitivity to the Antiproliferative Action of Interferon-α and Granulocyte-Macrophage Colony-Stimulating Factor in Monoblastic U937 Cells

  1992cites this paper
• Induction of 2'-5' oligoadenylate synthetase during interferon treatment of chronic myelogenous leukemia.

  1992cites this paper
• Priming affects the activity of a specific region of the promoter of the human beta interferon gene

  1990cites this paper
• Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours.

  1990cites this paper
• Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours.

  1990cites this paper
• Variant Human Neurobalstoma Cell Lines Resistant to the Differentiation-inducing Effect of Interferon-γ

  1989cites this paper
• Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.

  1989cites this paper
• Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway

  1989cites this paper
• Variant human neuroblastoma cell lines resistant to the differentiation-inducing effect of interferon-gamma.

  1989cites this paper
• Cloning and chromosomal location of human genes inducible by type I interferon

  1988cites this paper
• Isolation and characterization of interferon-resistant variants from S49 mouse lymphoma.

  1988cites this paper
• Alpha interferon accelerates lateral diffusion of Daudi cell surface differentiation antigens: measurement by fluorescence redistribution after photobleaching.

  1988cites this paper
• Regulation of two interferon-inducible human genes by interferon, poly(rI).poly(rC) and viruses.

  1988cites this paper
• Interferons-alpha/beta- and -gamma-resistant Friend cell variants exhibiting receptor sites for interferons but no induction of 2-5A synthetase and 67K protein kinase.

  1988cites this paper
• Interferon‐α‐(IFN) producing CHO cell lines are resistant to the antiproliferative activity of IFN: A correlation with gene expression

  1988cites this paper
• Interferons and oncogenes in the control of cell growth and differentiation: working hypothesis and experimental facts.

  1988cites this paper
• Interferons-α/β- and -γ-Resistant Friend Cell Variants Exhibiting Receptor Sites for Interferons but No Induction of 2-5A Synthetase and 67K Protein Kinase

  1988cites this paper
• Induction of 2',5'-oligoadenylate synthetase in freshly separated malignant cells from solid tumors. Variability in the susceptibility of interferon.

  1987cites this paper
• Characterization of an Interferon-Resistant Mutant of the Human Breast Cancer Cell Line BT-20

  1987cites this paper
• Interferons and their actions.

  1987cites this paper
• Relationship between inhibition of cell growth and of transferrin receptor expression by interferon (IFN) alpha: studies in IFN-sensitive and IFN-resistant Daudi cells.

  1987cites this paper
• A novel approach for understanding the effects of interferons--a working hypothesis.

  1987cites this paper
• Interferon-alpha down-regulates insulin receptors in lymphoblastoid (Daudi) cells. Relationship to inhibition of cell proliferation.

  1987cites this paper
• Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance

  1986cites this paper
• Induction of 2',5'-oligoadenylate synthetase and blast transformation in primary chronic lymphocytic leukemia cells following exposure to interferon in vitro.

  1986cites this paper
• Relationship of the clinical response and binding of recombinant interferon alpha in patients with lymphoproliferative diseases.

  1986cites this paper
• Isolation of Daudi cells with reduced sensitivity to interferon. IV. Characterization of clones with altered binding of human interferon alpha subspecies.

  1986cites this paper
• 2 – Interferon Receptors

  1986cites this paper
• Interferon treatment of human neoplasia.

  1986cites this paper
• The evolving role of alpha interferon in the treatment of malignancies.

  1986cites this paper
• In vitro response of cells from three patients with hairy cell leukemia to a recombinant leukocyte interferon

  1985cites this paper
• Isolation of Daudi cells with reduced sensitivity to interferon. III. Interferon-induced proteins in relation to the phenotype of interferon resistance.

  1985cites this paper
• Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages

  1985cites this paper
• Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.

  1985cites this paper
• Regulation of cell proliferation and differentiation by interferons.

  1985cites this paper
• Characteristics of the Induction of Two Double-Stranded RNA-Dependent Enzymes by Interferon in Parental and Variant L Cells

  1985cites this paper
• Cyclic GMP levels in interferon treated cells.

  1985cites this paper
• Receptor mediated pathways for interferon action:In vivo implications

  1984cites this paper
• Isolation of Daudi cells with reduced sensitivity to interferon. I. Characterization.

  1983cites this paper
• ox/I Decreases the Level of 2'-5' Oligoadenylate Synthetase in Peritoneal Macrophages

  year unknowncites this paper